Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/resource/nanopub/NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_provenance.
- NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_assertion description "[In this pilot study, we attempted to determine the optimal dosage regimens of esomeprazole for treatment of GERD with minimal influence of the CYP2C19 polymorphism through a study of the pharmacokinetics and pharmacodynamics of esomeprazole given at 3 different dosage regimens with the same total daily dose.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_provenance.
- NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_assertion evidence source_evidence_literature NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_provenance.
- NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_assertion SIO_000772 18751689 NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_provenance.
- NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_assertion wasDerivedFrom befree-2016 NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_provenance.
- NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_assertion wasGeneratedBy ECO_0000203 NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_provenance.
- befree-2016 importedOn "2016-02-19" NP689983.RAySeciGEXnZP6KAdGEWLfvU1LlX4ZZSzoC8v33Zw_qSM130_provenance.